11/24
04:01 pm
arct
Arcturus Therapeutics to Attend Upcoming Investor Conference
Medium
Report
Arcturus Therapeutics to Attend Upcoming Investor Conference
11/13
03:18 pm
arct
Arcturus Therapeutics (NASDAQ:ARCT) had its price target lowered by analysts at Citigroup Inc. from $12.00 to $9.00. They now have a "neutral" rating on the stock.
Low
Report
Arcturus Therapeutics (NASDAQ:ARCT) had its price target lowered by analysts at Citigroup Inc. from $12.00 to $9.00. They now have a "neutral" rating on the stock.
11/11
12:21 pm
arct
Arcturus Therapeutics (NASDAQ:ARCT) had its price target lowered by analysts at Piper Sandler from $140.00 to $72.00. They now have an "overweight" rating on the stock.
Low
Report
Arcturus Therapeutics (NASDAQ:ARCT) had its price target lowered by analysts at Piper Sandler from $140.00 to $72.00. They now have an "overweight" rating on the stock.
11/11
11:42 am
arct
Arcturus Therapeutics (NASDAQ:ARCT) had its price target lowered by analysts at HC Wainwright from $12.00 to $9.00. They now have a "neutral" rating on the stock.
Low
Report
Arcturus Therapeutics (NASDAQ:ARCT) had its price target lowered by analysts at HC Wainwright from $12.00 to $9.00. They now have a "neutral" rating on the stock.
11/11
12:30 am
arct
Arcturus Therapeutics Holdings Inc (ARCT) Q3 2025 Earnings Call Highlights: Navigating ... [Yahoo! Finance]
Low
Report
Arcturus Therapeutics Holdings Inc (ARCT) Q3 2025 Earnings Call Highlights: Navigating ... [Yahoo! Finance]
11/10
04:41 pm
arct
Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress [Yahoo! Finance]
Medium
Report
Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress [Yahoo! Finance]
11/10
04:18 pm
arct
Arcturus Therapeutics: Q3 Earnings Snapshot [Yahoo! Finance]
Medium
Report
Arcturus Therapeutics: Q3 Earnings Snapshot [Yahoo! Finance]
11/10
04:01 pm
arct
Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress
Low
Report
Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress
11/10
02:40 pm
arct
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) and Encourages Investors with Substantial Losses to Contact the Firm
Low
Report
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) and Encourages Investors with Substantial Losses to Contact the Firm
11/4
04:01 pm
arct
Arcturus Therapeutics to Attend Upcoming Investor Conferences
Medium
Report
Arcturus Therapeutics to Attend Upcoming Investor Conferences
10/28
04:01 pm
arct
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 10, 2025
Medium
Report
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 10, 2025
10/28
10:00 am
arct
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcturus Therapeutics Holdings Inc. - ARCT
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcturus Therapeutics Holdings Inc. - ARCT
10/28
06:18 am
arct
Arcturus Therapeutics (NASDAQ:ARCT) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medium
Report
Arcturus Therapeutics (NASDAQ:ARCT) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
10/25
11:38 am
arct
Could ARCT's Latest CF Trial Data Shift Expectations for Its Pipeline Potential? [Yahoo! Finance]
Medium
Report
Could ARCT's Latest CF Trial Data Shift Expectations for Its Pipeline Potential? [Yahoo! Finance]
10/24
10:00 am
arct
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcturus Therapeutics Holdings Inc. - ARCT
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcturus Therapeutics Holdings Inc. - ARCT
10/24
08:06 am
arct
Arcturus Therapeutics (NASDAQ:ARCT) had its "neutral" rating reaffirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock, down previously from $60.00.
Medium
Report
Arcturus Therapeutics (NASDAQ:ARCT) had its "neutral" rating reaffirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock, down previously from $60.00.
10/23
09:33 am
arct
Arcturus Therapeutics (NASDAQ:ARCT) had its price target lowered by analysts at Wells Fargo & Company from $42.00 to $20.00. They now have an "overweight" rating on the stock.
Medium
Report
Arcturus Therapeutics (NASDAQ:ARCT) had its price target lowered by analysts at Wells Fargo & Company from $42.00 to $20.00. They now have an "overweight" rating on the stock.
10/23
08:31 am
arct
Arcturus Therapeutics (NASDAQ:ARCT) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $12.00 price target on the stock.
Medium
Report
Arcturus Therapeutics (NASDAQ:ARCT) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $12.00 price target on the stock.
10/10
07:20 am
arct
Arcturus Therapeutics (NASDAQ:ARCT) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Arcturus Therapeutics (NASDAQ:ARCT) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
10/3
03:30 pm
arct
Arcturus Therapeutics (NASDAQ:ARCT) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Arcturus Therapeutics (NASDAQ:ARCT) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
9/23
04:16 am
arct
Arcturus Therapeutics Shows Progress Amid Transition: Why I Assign A Hold Rating [Seeking Alpha]
Medium
Report
Arcturus Therapeutics Shows Progress Amid Transition: Why I Assign A Hold Rating [Seeking Alpha]
9/19
08:23 am
arct
Arcturus Therapeutics (ARCT) Surges 8.7%: Is This an Indication of Further Gains? [Yahoo! Finance]
Low
Report
Arcturus Therapeutics (ARCT) Surges 8.7%: Is This an Indication of Further Gains? [Yahoo! Finance]
9/15
08:30 am
arct
Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth
Medium
Report
Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth